Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



A Changing Regulatory Environment for Healthcare Products in Sub-Saharan Africa - The Regulatory Environment for Pharmaceutical Products and Medical Devices in Key sub-Saharan African Countries
A Changing Regulatory Environment for Healthcare Products in Sub-Saharan Africa

 

PRZOOM - /newswire/ - Cape Town, South Africa, 2007/08/08 - The Regulatory Environment for Pharmaceutical Products and Medical Devices in Key sub-Saharan African Countries.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Due to the high burden of disease in sub-Saharan Africa (SSA) and growing pressure from international organisations, governments are multiplying efforts to control the quality of pharmaceutical products and medical devices available in the market.

“In an effort to reduce the prevalence of sub-standard products in the market, several drug regulatory authorities are drafting and implementing regulations for the control of medical devices,” notes Frost & Sullivan (pharmaceutical.frost.com) Analyst Tiwonge Mkandawire. “This is coupled with more stringent controls already in place for most pharmaceutical products.”

Medical devices in most SSA countries are typically treated as ‘normal commodities’ and are not being controlled by any kind of specific regulations required to protect patients and users. While a regulatory framework is in place for pharmaceutical products, implementing these standards brings its own set of challenges, such as a lack of specific scientific knowledge for drug regulation and insufficient financial resources.

Easily available counterfeit and inferior medical devices and pharmaceutical products in SSA countries pose a very real threat to internationally approved products of superior quality. Inadequate buying power of end users to purchase high-end products is another factor that allows the counterfeit and low-cost drug and medical device market to flourish.

“SSA countries need to develop effective legislation and control measures or modify existing regulations to ensure proper control,” says Mkandawire. “An improved regulatory environment is necessary to support the market potential that the SSA countries present.”

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) has already introduced strict restrictions on distribution channels in an attempt to curb the rampant availability of counterfeit drugs. The main focus is on encouraging the growth of the local manufacture and distribution of pharmaceutical products and medical devices.

The Kenyan and South African Governments are also framing regulations for the registration of medical devices that could well be implemented in the near future. There are currently no guidelines or systems in place for the registration and control of medical devices in either of these countries. In South Africa, products to be placed on the market generally have to be either FDA-approved or carry the CE mark, especially in the case of higher risk products.

Overall, most SSA countries are experiencing significant economic growth, suggesting that there is considerable market potential for pharmaceuticals and medical device companies to exploit.

However, companies will need to cultivate a thorough understanding of the regulatory landscape, its requirements and challenges to develop appropriate and effective strategies for market penetration. Additionally, developing sound relationships with local distributors and relevant regulatory bodies could help ensure the smooth placement of products on the market.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the latest analysis of the Regulatory Environment for Pharmaceutical Products and Medical Devices in Key sub-Saharan African Countries, then send an email to Patrick Cairns, Corporate Communications, at patrick.cairns[.]frost.com with your full name, company name, title, telephone number, fax number and email address. Upon receipt of the above information, an overview will be sent to you by email.

The Regulatory Environment for Pharmaceutical Products and Medical Devices in Key sub-Saharan African Countries is part of the Pharmaceutical Growth Partnership Service program, which also includes research on the following: Strategic Assessment of Healthcare and Medical Device Markets in Key Sub-Saharan African Countries, South African Implantable Cardiovascular Device Market, and Infectious Disease Diagnostics Markets in sub-Saharan Africa. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


A Changing Regulatory Environment for Healthcare Products in Sub-Saharan Africa

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Patrick Cairns 
+27 21 680 3274 patrick.cairns[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today